Format

Send to

Choose Destination
Pharmacotherapy. 2015 May;35(5):520-35. doi: 10.1002/phar.1584. Epub 2015 May 4.

Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.

Author information

1
Department of Pharmacy, Mayo Clinic, Rochester, Minnesota.
2
Department of Pharmacy, University of North Carolina Hospitals, Chapel Hill, North Carolina.
3
Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland.

Abstract

Nonsteroidal antiinflammatory drugs (NSAIDs) are used in the management of a variety of conditions, but their prevalence is likely underreported as a result of widespread availability and the perception that nonprescription therapies are unnecessary to report during medication history taking. However, NSAIDs are associated with a number of adverse effects, especially in patients with cardiovascular disease (CVD). Patients with CVD and comorbidities for which NSAIDs may provide symptomatic relief (e.g., osteoarthritis, rheumatoid arthritis) tend to be older, which places them at greater risk of harm. For these reasons, the use of NSAIDs in patients with CVD is a significant public health concern. An understanding of the risks associated with NSAIDs is critical for clinicians across practice settings. In this review, we detail the safety of NSAIDs in patients with CVD, provide recommendations on their use in specific disease states, and discuss therapeutic alternatives.

KEYWORDS:

bleeding; cardiac surgery; cardiovascular disease; noncardiac surgery; nonsteroidal antiinflammatory drugs

PMID:
25940579
DOI:
10.1002/phar.1584
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center